Drugs / Lobucavir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00002352 | — | HIV infectious disease, cytomegalovirus infection | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lobucavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002352 ↗ |
| Known as | BMS-180194 | ChEMBL registry synonym — accepted as the source's own label CHEMBL23550 ↗ |
| Known as | SQ 34,514 | ChEMBL registry synonym — accepted as the source's own label CHEMBL23550 ↗ |
| Modality | Small molecule | — CHEMBL23550 ↗ |
| Route | Oral | “Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients” NCT00002352 ↗ |